Advanced Course in Immunology On Demand Lecture Recordings-Neuroimmunology

Video Transcription

Video Summary

The speaker gave a wide-ranging overview of neuroimmunology, focusing on how the brain interacts with the immune system. He began by describing major brain cell types, especially microglia, the resident macrophages of the brain, and explained how views of microglia have shifted from “resting” cells to highly dynamic immune cells. He reviewed evidence on their embryonic origin, their ability to self-renew, and how peripheral monocytes can enter the brain under injury or inflammation and adopt microglia-like functions.<br /><br />A major theme was that the brain is not truly “immune privileged.” Instead, it has specialized barriers and immune routes: the blood-brain barrier, meninges, choroid plexus, arachnoid, glymphatic flow, and meningeal lymphatic vessels. These structures regulate entry and exit of immune cells and molecules rather than completely blocking them. The speaker emphasized that immune activity is especially concentrated in the meninges, particularly the dura near venous sinuses, where antigen-presenting cells and T cells are abundant.<br /><br />He also discussed the skull and vertebral bone marrow as sources of immune cells that can reach the meninges through vascular channels, and showed that cerebrospinal fluid can carry brain-derived antigens outward, influencing immune education in nearby tissues. Finally, he introduced the idea of “guardian peptides,” self-peptides presented in the dura that may help maintain immune tolerance and suppress inflammation, with implications for diseases like multiple sclerosis and brain tumors.

Asset Subtitle

Lecture 18: Jonathan Kipnis, Washington University School of Medicine

Neuroimmunology

Asset Caption

Jonathan Kipnis, Washington University School of Medicine
Neuroimmunology

Keywords

neuroimmunology

microglia

blood-brain barrier

meninges

choroid plexus

glymphatic system

meningeal lymphatic vessels

immune privilege

cerebrospinal fluid

antigen presentation

multiple sclerosis

brain tumors